Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents.

[1]  Nai Zhou,et al.  5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance. , 2005, Journal of medicinal chemistry.

[2]  E. LaVoie,et al.  Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity. , 2004, Bioorganic & medicinal chemistry letters.

[3]  E. LaVoie,et al.  Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicity. , 2004, Bioorganic & medicinal chemistry.

[4]  Alexander L. Ruchelman,et al.  Cytotoxicity of 5H-Dibenzo[c,h][1,6]naphthyridin-6-ones and 6H-Indeno[1,2-c]isoquinolin-5,11-diones in Tumor Cells Sensitive and Resistant to Camptothecin Analogs , 2004 .

[5]  A. Ray,et al.  11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity. , 2004, Bioorganic & medicinal chemistry.

[6]  Peter J Houghton,et al.  Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. , 2003, Cancer research.

[7]  E. LaVoie,et al.  Aza-analogs of dibenzo[c,h]cinnoline: Triazachrysenes as potent topoisomerase I-targeting anticancer agents , 2003 .

[8]  E. LaVoie,et al.  5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation. , 2003, Bioorganic & medicinal chemistry letters.

[9]  E. LaVoie,et al.  8,9-methylenedioxybenzo[i]phenanthridines: topoisomerase I-targeting activity and cytotoxicity. , 2003, Bioorganic & medicinal chemistry.

[10]  E. LaVoie,et al.  Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity. , 2003, Journal of medicinal chemistry.

[11]  A. Ray,et al.  5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity. , 2003, Bioorganic & medicinal chemistry.

[12]  E. LaVoie,et al.  Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents. , 2003, Bioorganic & medicinal chemistry.

[13]  E. LaVoie,et al.  2,3-Dimethoxybenzo[i]phenanthridines: topoisomerase I-targeting anticancer agents. , 2003, Bioorganic & medicinal chemistry.

[14]  A. Ray,et al.  Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435. , 2002, Bioorganic & medicinal chemistry letters.

[15]  R. SanMartin,et al.  Revisiting the Ullmann-ether reaction: a concise and amenable synthesis of novel dibenzoxepino[4,5-d]pyrazoles by intramolecular etheration of 4,5-(o,o'-halohydroxy)arylpyrazoles. , 2002, The Journal of organic chemistry.

[16]  L. Liu,et al.  Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. , 2001, Biochemistry.

[17]  L. Doyle,et al.  Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. , 2001, Biochemical and biophysical research communications.

[18]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[19]  M. Kuo,et al.  BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. , 2000, Biochemical pharmacology.

[20]  W. Scherer,et al.  Volatile Donor-Functionalized Alkoxy Derivatives of Lutetium and Their Structural Characterization(1). , 1997, Inorganic chemistry.

[21]  Y. Sugiyama,et al.  Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats. , 1997, Cancer research.

[22]  B. Gatto,et al.  Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne. , 1996, Cancer research.

[23]  D. Kufe,et al.  Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. , 1994, The Journal of biological chemistry.

[24]  T. Burke,et al.  Ethyl substitution at the 7 position extends the half-life of 10-hydroxycamptothecin in the presence of human serum albumin. , 1993, Journal of medicinal chemistry.

[25]  T. Burke,et al.  Preferential binding of the carboxylate form of camptothecin by human serum albumin. , 1993, Analytical biochemistry.

[26]  G. Weiss,et al.  A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days , 1992, Anti-cancer drugs.

[27]  C. Yu,et al.  Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. , 1991, Cancer research.

[28]  J. Gervasoni,et al.  Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. , 1991, Cancer research.

[29]  L. Liu,et al.  Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.

[30]  Y. Suzuki,et al.  Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[31]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[32]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[33]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[34]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[35]  L. Liu,et al.  DNA topoisomerases: essential enzymes and lethal targets. , 1994, Annual review of pharmacology and toxicology.

[36]  R. Hertzberg,et al.  Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. , 1992, Oncology research.

[37]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[38]  D. B. Luten.  THE PREPARATION OF AMINONITRILES AND THEIR QUATERNARY AMMONIUM DERIVATIVES , 1939 .